Qiaomin Wu

764 total citations · 2 hit papers
18 papers, 404 citations indexed

About

Qiaomin Wu is a scholar working on Molecular Biology, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Qiaomin Wu has authored 18 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Complementary and alternative medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Qiaomin Wu's work include Traditional Chinese Medicine Analysis (9 papers), Mitochondrial Function and Pathology (6 papers) and Ginseng Biological Effects and Applications (3 papers). Qiaomin Wu is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Mitochondrial Function and Pathology (6 papers) and Ginseng Biological Effects and Applications (3 papers). Qiaomin Wu collaborates with scholars based in China and United Kingdom. Qiaomin Wu's co-authors include Ruxiu Liu, Xuanke Guan, Xing Chang, Jinfeng Liu, Yanli Wang, Zhiming Liu, Qin Zhang, Siyuan Zhou, Yu Huang and Xinai Zhang and has published in prestigious journals such as Journal of Ethnopharmacology, Medicine and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Qiaomin Wu

17 papers receiving 401 citations

Hit Papers

Quercetin inhibits necroptosis in cardiomyocytes after is... 2024 2026 2025 2024 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quercetin inhibits necroptosis in cardiomyocytes after ischemia–reperfusion via DNA‐PKcs‐SIRT5‐orchestrated mitochondrial quality control
    2024 86 citations Xing Chang, Qin Zhang et al. Phytotherapy Research profile →
  2. Ginsenoside Rb1 ameliorates heart failure through DUSP-1-TMBIM-6-mediated mitochondrial quality control and gut flora interactions
    2024 43 citations Qin Zhang, Jinfeng Liu et al. Phytomedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaomin Wu China 8 239 78 70 66 48 18 404
Xuanke Guan China 8 255 1.1× 83 1.1× 75 1.1× 69 1.0× 56 1.2× 16 413
Xing Chang China 10 254 1.1× 73 0.9× 55 0.8× 88 1.3× 26 0.5× 20 412
Ke‐Xue Li China 12 207 0.9× 83 1.1× 95 1.4× 63 1.0× 20 0.4× 17 465
Agnieszka Biala Canada 10 186 0.8× 69 0.9× 68 1.0× 74 1.1× 13 0.3× 11 349
Wenwei Luo China 11 176 0.7× 42 0.5× 39 0.6× 56 0.8× 14 0.3× 29 373
Saizhu Wu China 13 168 0.7× 85 1.1× 48 0.7× 75 1.1× 17 0.4× 20 429
Yinglu Feng China 9 155 0.6× 47 0.6× 31 0.4× 34 0.5× 32 0.7× 19 340
Chuanshi Xiao China 11 166 0.7× 96 1.2× 77 1.1× 63 1.0× 10 0.2× 24 390
Cheng Shen China 14 274 1.1× 95 1.2× 197 2.8× 65 1.0× 26 0.5× 35 547
Zhi Qi China 10 148 0.6× 34 0.4× 59 0.8× 35 0.5× 19 0.4× 17 330

Countries citing papers authored by Qiaomin Wu

Since Specialization
Citations

This map shows the geographic impact of Qiaomin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaomin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaomin Wu more than expected).

Fields of papers citing papers by Qiaomin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaomin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaomin Wu. The network helps show where Qiaomin Wu may publish in the future.

Co-authorship network of co-authors of Qiaomin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaomin Wu. A scholar is included among the top collaborators of Qiaomin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaomin Wu. Qiaomin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Chang, Xing, Siyuan Zhou, Qin Zhang, et al.. (2025). Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural Products. Phytotherapy Research. 39(8). 3353–3385. 9 indexed citations
3.
Wu, Qiaomin, Zhaoqi Yan, Siyuan Zhou, et al.. (2025). Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury. Phytomedicine. 145. 156982–156982. 10 indexed citations
4.
Chang, Xing, Siyuan Zhou, Yu Huang, et al.. (2025). Zishen Huoxue decoction (ZSHX) alleviates ischemic myocardial injury (MI) via Sirt5-β-tubulin mediated synergistic mechanism of “mitophagy-unfolded protein response” and mitophagy. Chinese Journal of Natural Medicines. 23(3). 311–321. 2 indexed citations
5.
Zhou, Hao, et al.. (2025). Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review. Frontiers in Pharmacology. 16. 1528208–1528208. 2 indexed citations
6.
Chang, Xing, Qin Zhang, Jinfeng Liu, et al.. (2024). The effect of unhealthy lifestyle on the pathogenesis of sick sinus syndrome: A life-guiding review. Medicine. 103(43). e39996–e39996. 4 indexed citations
7.
Wang, Yanli, Qiaomin Wu, Jinfeng Liu, et al.. (2024). Mechanisms involved in the regulation of mitochondrial quality control by PGAM5 in heart failure. Cell Stress and Chaperones. 29(3). 510–518. 7 indexed citations
8.
Wu, Qiaomin, Xing Chang, Yanli Wang, et al.. (2024). The electrophysiological effects of Tongyang Huoxue granules on the ignition phase during hypoxia/reoxygenation injury in sinoatrial node cells. Frontiers in Physiology. 15. 1402478–1402478. 1 indexed citations
9.
Wu, Qiaomin, Yanli Wang, Jinfeng Liu, et al.. (2024). Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies. The International Journal of Biochemistry & Cell Biology. 175. 106650–106650. 6 indexed citations
10.
Zhang, Qin, Jinfeng Liu, Yanli Wang, et al.. (2024). Ginsenoside Rb1 ameliorates heart failure through DUSP-1-TMBIM-6-mediated mitochondrial quality control and gut flora interactions. Phytomedicine. 132. 155880–155880. 43 indexed citations breakdown →
11.
Chang, Xing, Qin Zhang, Yu Huang, et al.. (2024). Quercetin inhibits necroptosis in cardiomyocytes after ischemia–reperfusion via DNA‐PKcs‐SIRT5‐orchestrated mitochondrial quality control. Phytotherapy Research. 38(5). 2496–2517. 86 indexed citations breakdown →
12.
13.
14.
Chang, Xing, Siyuan Zhou, Jinfeng Liu, et al.. (2023). Zishen Tongyang Huoxue decoction (TYHX) alleviates sinoatrial node cell ischemia/reperfusion injury by directing mitochondrial quality control via the VDAC1–β-tubulin signaling axis. Journal of Ethnopharmacology. 320. 117371–117371. 67 indexed citations
15.
Wu, Qiaomin, et al.. (2023). Roles and mechanisms of natural drugs on sinus node dysfunction. Biomedicine & Pharmacotherapy. 164. 114777–114777. 6 indexed citations
16.
Wu, Qiaomin, et al.. (2023). Reliability, validity, and sensitivity of short-form 36 health survey (SF-36) in patients with sick sinus syndrome. Medicine. 102(24). e33979–e33979. 15 indexed citations
17.
Wang, Yanli, et al.. (2022). The Effect of the Tongyang Huoxue Recipe (TYHX) on the Ito/IKur in Ischemia/Reperfusion Sinoatrial Node Cells. Cardiovascular Therapeutics. 2022. 1–11. 4 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuanke Guan Breakdown of academic impact, for papers by Xing Chang Breakdown of academic impact, for papers by Ke‐Xue Li Breakdown of academic impact, for papers by Agnieszka Biala Breakdown of academic impact, for papers by Wenwei Luo Breakdown of academic impact, for papers by Saizhu Wu Breakdown of academic impact, for papers by Yinglu Feng Breakdown of academic impact, for papers by Chuanshi Xiao Breakdown of academic impact, for papers by Cheng Shen Breakdown of academic impact, for papers by Zhi Qi
Rankless by CCL
2026